Other Information.
−Removed: During the three months ended September 30, 2025, none of our directors or officers informed us of the adoption or termination of a trading plan intended to satisfy Rule 10b5-1 (c).
−Removed: Equity Purchase Agreement, dated as of October 7, 2025, by and among the Company and Purchaser (incorporated by reference to Exhibit 2.1 to the registrant’s Current Report on Form 8-K filed on October 7, 2025).
+Added: During the three months ended March 31, 2026, none of our directors or officers informed us of the adoption or termination of a trading plan intended to satisfy Rule 10b5-1 (c).
+Added: Composite Amended and Restated Articles of Incorporation of Accendra Health, Inc.
+Added: – filed herewith
+Added: Form of 2026 cash settled Performance Unit Award Agreement – filed herewith**
+Added: Form of 2026 share settled Performance Unit Award Agreement – filed herewith**
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
11 unchanged sentences
Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101)
+Added: ** Management contract or compensatory plan or arrangement
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: Owens & Minor, Inc.
−Removed: October 30, 2025
+Added: Accendra Health, Inc.
/s/ Edward A.
President, Chief Executive Officer & Director
−Removed: October 30, 2025
/s/ Jonathan A.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.